Access to medicines

Access to medicines

One third of the world lacks  access to essential medicines.  In the poorest parts of Africa and Asia this figure rises to a half of the population. We challenge the high cost of medicines and the absence of treatment for many of the diseases affecting ou

Too often  we cannot treat patients because the medicines are too expensive, or they are no longer produced.  Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure. 
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases. 

 
Access to medicines

MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public

Press Release 11 Nov 2020
 
Access to medicines

MSF calls on Kenya to support landmark move to ban patents on COVID medicines and tools

Press Release 15 Oct 2020
 
Round of medical staff in the COVID-19 patients ward.
Access to medicines

Access to coronavirus diagnostic tools is crucial to the response - An example from Cameroon

Project Update 13 Aug 2020
 
Access to medicines

Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment

Press Release 6 Jul 2020
 
Access to medicines

African Union says urgent need to address patents and technology barriers for access to future COVID-19 vaccine

Press Release 1 Jul 2020
 
Access to medicines

Ahead of Gavi Board meeting, MSF calls on Gavi to revise its global mechanism and demand pharma sell all COVID-19 vaccines at cost

Press Release 23 Jun 2020